ELEVANCE HEALTH INC (ELV)

US0367521038 - Common Stock

402.55  -1.05 (-0.26%)

After market: 402 -0.55 (-0.14%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to ELV. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 563.11. This target is 39.89% above the current price.
ELV was analyzed by 28 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ELV.
In the previous month the buy percentage consensus was at a similar level.
ELV was analyzed by 28 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 402.55469.65563.36563.11698.25 - 16.67% 39.95% 39.89% 73.46%
Up and Down Grades
Date Firm Action Rating
2024-11-05 Mizuho Maintains Outperform -> Outperform
2024-11-04 Wells Fargo Maintains Overweight -> Overweight
2024-10-23 Morgan Stanley Maintains Overweight -> Overweight
2024-10-22 Barclays Maintains Overweight -> Overweight
2024-10-21 TD Cowen Maintains Buy -> Buy
2024-10-18 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-10-18 Argus Research Downgrade Buy -> Hold
2024-10-18 UBS Maintains Buy -> Buy
2024-10-18 RBC Capital Maintains Outperform -> Outperform
2024-10-18 Truist Securities Reiterate Buy -> Buy
2024-10-10 Barclays Maintains Overweight -> Overweight
2024-10-01 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-05 Stephens & Co. Reiterate Overweight -> Overweight
2024-08-19 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-23 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-22 Wells Fargo Maintains Overweight -> Overweight
2024-07-19 TD Cowen Maintains Buy -> Buy
2024-07-18 RBC Capital Maintains Outperform -> Outperform
2024-07-18 Barclays Maintains Overweight -> Overweight
2024-07-18 B of A Securities Downgrade Buy -> Neutral
2024-07-15 Truist Securities Maintains Buy -> Buy
2024-07-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-24 Morgan Stanley Initiate Overweight
2024-06-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-11 Stephens & Co. Reiterate Overweight -> Overweight
2024-06-04 B of A Securities Maintains Buy -> Buy
2024-05-30 JP Morgan Maintains Overweight -> Overweight
2024-05-30 Baird Initiate Outperform